CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company creating personalized therapeutics based on breakthrough discoveries in the field of epigenetics, announced that data related to the Company’s programs will be the subject of multiple oral presentations at the 52nd American Society of Hematology (ASH) Annual Meeting and Exhibition. ASH is being held December 4-7, 2010 in Orlando, Florida.
